FT : Maserati/IPO: business model needs tuning for listings race

Maserati/IPO: business model needs tuning for listings race
The Italian group may find it difficult to go head to head with super sports car brands, but it is charting a different route


Can you hear a faint roar in the distance? It might be the sound of Maserati heading to the public markets. The Italian luxury sports car maker is still miles from that destination. But it is already a separate business within carmaker Stellantis.

With Porsche up almost 40 per cent since its float last year and Ferrari’s valuation thundering ahead, the market is starting to do a spot of window shopping. 

Maserati is midway through a strategic U-turn. It is seeking to focus on profits rather than sales. It has spruced up its range, adding the MC20 model with a £200,000 price tag.

Revenues are growing again after a few tricky years, up 15 per cent in 2022 to €2.3bn. Ebit margins have also recovered, to 8.7 per cent in 2022. It is targeting 15 per cent by 2024 and 20 per cent longer term. No listing is likely before then.

Today, Maserati is miles behind Porsche and Ferrari. The average selling price of its cars is under €100,000, according to Bernstein analysis — not that different from pricier Mercedes or BMW cars. Ferraris can cost €500,000 or more. Porsche — whose models run a wide gamut — has higher volumes to lend a helping hand.

Maserati may find it difficult to go head to head with super sports car brands. But it is charting a different route. Maserati has pledged to bring out an electric version of all its models by 2025, and to go entirely electric by 2030. That is a canny move. It should help Maserati attract a different type of customer, not least among eco-conscious tech entrepreneurs. 

How much might Maserati be worth? On today’s paltry margin, it would not deserve much of a premium to the likes of BMW, whose enterprise value is around one times last year’s sales. But the group does have room to raise profitability as it focuses on pricier models. If one — generously — applied Porsche’s valuation of 2.6 times last year’s sales, that would raise its enterprise value to €6bn.

Of course, the market would need to see continued evidence of a well-executed turnround before it gave the carmaker anything like that sort of accolade. Stellantis is right to keep Maserati in the garage until its engines are firing on all cylinders again.

FT : Nestlé says less than half of its mainstream food and drinks are considered

Nestlé says less than half of its mainstream food and drinks are considered ‘healthy’
World’s biggest food company discloses nutritional value of its portfolio for the first time

Nestlé has acknowledged that the nutritional value of less than half its portfolio of mainstream food and drinks can be considered “healthy” using a commonly accepted definition, despite pressure on packaged foodmakers to make their products more nutritious.

The annual report of the world’s largest food company showed 54 per cent of its food and beverages by revenue — excluding products such as pet food, baby food, vitamins and specialised medical nutrition — were rated lower than 3.5 under the widely used health star rating (HSR) system.

Foods with a lower score are not considered to be “generally healthy”, according to the not-for-profit Access to Nutrition Initiative. HSR takes into account the level of saturated fats, sugar and salt within individual products, as well as “positive nutrients” such as fibre, fruit and vegetables.

Nestlé, whose products include Smarties chocolates, Nesquik milkshake and Nescafé coffee, released the figures following pressure from some shareholders and campaigners for the industry to be more transparent about the nutritional value of its products.

The Switzerland-based group said it was “setting a standard for transparency” and was the first in the sector “to report on the nutritional value of its entire global portfolio”.

Holly Gabriel, a campaigner at responsible investment charity ShareAction, welcomed the disclosure but said it “worryingly shows the company is still far too reliant on the sale of less healthy food and drink products”.

Packaged food groups are under scrutiny over the extent to which they are responsible for a global obesity problem. In an attempt to improve diets, some governments have introduced taxes on high-sugar products and implemented restrictions on advertising and sales promotions.

Nestlé chief executive Mark Schneider told analysts on an earnings call last month that the group had made “already a lot of progress” in reducing sodium, sugar and saturated fats.

The foodmaker said it had recently reduced sodium in products including Mahler Seafood Creamy Soup, introduced more zero-sugar variants of Coffee Mate and launched more plant-based foods, including Garden Gourmet Schnitzel.

But industry executives have argued there are limits to how much they can push healthier products, especially as inflation has squeezed consumer spending and pushed up the industry’s costs.

“It’s clear that while the work goes on, there are limits,” Schneider said. “Enjoyment-related categories [such as confectionery] will not be turned into health-related categories.”

In its annual report, Nestlé broke down its net sales into four categories: 17 per cent came from products with an HSR score of less than 1.5, 18 per cent from those scoring between 1.5 and 3.5, and 30 per cent with a rating of at least 3.5. The remaining 35 per cent came from petcare and other products for which HSR is not applicable.

The data was compiled by the company and audited by the third party Bureau Veritas. Nestlé disclosed the figures for the first time on Tuesday, although the Financial Times reported about two years ago on an internal company presentation that also showed a high proportion of its portfolio scored lower than 3.5 on the scale.

Mark Wijne, research director at the Access to Nutrition Initiative, also said the disclosure was “very welcome” but showed companies such as Nestlé could and should do more to innovate and promote healthier alternatives.

Nestlé added that it had “come a long way and now want to go further. We have committed to setting a global target for the healthier part of our portfolio later this year.”

HSR was originally developed by authorities in Australia and is now also used by investors and policymakers globally.

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • ONON +13.8%, CSIQ +8.2%

Other news:

  • SELB +23.4% (reports Phase 3 DISSOLVE Program of SEL-212 in chronic refractory gout meets primary endpoint)
  • HLIT +8.6% (partners with Charter Communications)
  • GRIN +4.2% (appoints new CEO and CFO)
  • NNDM +3.1% (shareholders approve Murchinson's proposals)
  • BB +3% (announces new patent sale transaction with leading patent monetization company for up to $900 million)
  • NTLA +3% (announces FDA regenerative medicine advanced therapy designation granted to NTLA-2002)
  • BBIO +2.7% (Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan)
  • SLRC +2.4% (notes that bank issues will not impact operations)
  • CNI +2.3% (Canadian Nat'l Rail and Unifor reach tentative agreements)
  • TSLA +1.9% (assigned Baa3 rating)
  • SNY +1.9% (Sanofi and Regeneron Pharmaceuticals (REGN) receives EC approval for Dupixent)
  • CDAY +1.8% (selected by Orica for HR and payroll)
  • FUSN +1.3% (first patient in Phase 1 FPI-2059 study dosed)
  • AFCG +1.2% (appoints new CFO)

Analyst comments:

  • FLT +3.9% (upgraded to Outperform from Mkt Perform at Raymond James)
  • HOG +3.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • WIX +3.3% (upgraded to Overweight from Neutral at Piper Sandler)
  • META +2.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • EMR +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)

>>> US Research Calls

Research Calls

  • Upgrades:
    • Assurant (AIZ) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt $52
    • Emerson (EMR) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $96
    • FleetCor (FLT) upgraded to Outperform from Mkt Perform at Raymond James; tgt $254
    • Foot Locker (FL) upgraded to Buy from Neutral at Citigroup; tgt raised to $50
    • Foot Locker (FL) upgraded to Outperform from In-line at Evercore ISI; tgt $60
    • Harley-Davidson (HOG) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $50
    • Imperial Oil (IMO) upgraded to Sector Outperform from Sector Perform at Scotiabank
    • J. Sainsbury plc (JSAIY) upgraded to Outperform from Neutral at Exane BNP Paribas
    • Meta Platforms (META) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $250
    • New York Community (NYCB) upgraded to Buy from Neutral at DA Davidson; tgt $11.50
    • Proximus (BGAOY) upgraded to Neutral from Sell at UBS
    • Range Resources (RRC) upgraded to Buy from Hold at Tudor, Pickering, Holt & Co.; tgt $33
    • TotalEnergies SE (TTE) upgraded to Overweight from Equal-Weight at Morgan Stanley
    • Vornado Rlty Trust (VNO) upgraded to Neutral from Underweight at Piper Sandler; tgt lowered to $16
    • Wix.com (WIX) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $120
  • Downgrades:
    • Agree Realty (ADC) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • Armstrong World Industries (AWI) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $77
    • GoDaddy (GDDY) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $88
    • Profound Medical (PROF) downgraded to Hold from Buy at Jefferies; tgt raised to $10
    • Suncor Energy (SU) downgraded to Sector Perform from Sector Outperform at Scotiabank
    • Sutro Biopharma (STRO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $8
    • Svenska Handelsbanken (SVNLY) downgraded to Equal Weight from Overweight at Barclays
  • Others:
    • Allogene (ALLO) initiated with a Mkt Perform at Bernstein; tgt $6
    • Alnylam Pharma (ALNY) initiated with an Outperform at Bernstein; tgt $243
    • Alphabet A (GOOGL) resumed with a Buy at Stifel; tgt $130
    • Arrowhead (ARWR) initiated with a Mkt Perform at Bernstein; tgt $27
    • Beam Therapeutics (BEAM) initiated with a Mkt Perform at Bernstein; tgt $37
    • BioMarin Pharmaceutical (BMRN) initiated with an Underperform at Bernstein; tgt $81
    • Boston Properties (BXP) resumed with a Neutral at Goldman; tgt $56
    • Brixmor Property (BRX) resumed with a Neutral at Goldman; tgt $22
    • Carnival (CCL) named Catalyst Call Buy short-term investment idea at Deutsche Bank
    • CRISPR Therapeutics (CRSP) initiated with a Mkt Perform at Bernstein; tgt $44
    • Chart Industries (GTLS) initiated with an Outperform at Evercore ISI; tgt $217
    • CONMED (CNMD) initiated with an Equal Weight at Wells Fargo; tgt $96
    • First Industrial Realty (FR) resumed with a Sell at Goldman; tgt $48
    • Hudson Pacific Properties (HPP) resumed with a Sell at Goldman; tgt $5.50
    • Intellia Therapeutics (NTLA) initiated with an Outperform at Bernstein; tgt $54
    • Ionis Pharma (IONS) initiated with an Underperform at Bernstein; tgt $31
    • Kilroy Realty (KRC) resumed with a Buy at Goldman; tgt $41
    • Kimco Realty (KIM) resumed with a Buy at Goldman; tgt $25
    • Macerich (MAC) resumed with a Sell at Goldman; tgt $8.50
    • Phillips Edison & Company (PECO) resumed with a Buy at Goldman; tgt $38
    • Prologis (PLD) resumed with a Buy at Goldman; tgt $147
    • Rain Oncology (RAIN) initiated with an Outperform at SVB Securities; tgt $11
    • Simon Properties (SPG) resumed with a Buy at Goldman; tgt $150
    • SL Green Realty (SLG) resumed with a Sell at Goldman; tgt $18
    • Tanger Factory (SKT) resumed with a Buy at Goldman; tgt $22
    • Vertex Pharma (VRTX) initiated with an Outperform at Bernstein; tgt $344
    • Ventyx Biosciences (VTYX) initiated with an Overweight at Wells Fargo; tgt $77
    • Vornado Rlty Trust (VNO) resumed with a Sell at Goldman; tgt $12
    • Zymeworks (ZYME) assumed with an Overweight at Wells Fargo; tgt $12

>>> U S Gapping down

Gapping down
In reaction to earnings/guidance
:

  • HUYA -6.9%, TME -1.5%

Other news:

  • ALT -39.6% (results from week 24 interim analysis of pemvidutide momentum phase 2 obesity trial and 12-week phase 1b type 2 diabetes safety trial)
  • AG -15.2% (suspending mining at Jerritt Canyon)
  • SI -6% (delaying 10-K filing)
  • FSM -2.5% (reports updated Mineral Reserves and Mineral Resources)
  • FMC -2.3% (to introduce long-range growth plan)
  • CTRE -1.5% (increases quarterly dividend)
  • PBT -1.5% (announces March cash distribution)
  • KRTX -1.4% (commences $400 mln public offering)

Analyst comments:

  • GDDY -1.4% (downgraded to Neutral from Overweight at Piper Sandler)

WWD : Inside Foot Locker’s Plan to Reach $9.5 Billion in Sales by 2026

Inside Foot Locker’s Plan to Reach $9.5 Billion in Sales by 2026
The footwear retailer also beat fourth-quarter expectations.

Foot Locker and chief executive officer Mary Dillon rolled out a multipronged strategy Monday to help the retailer increase market share and grow sales to $9.5 billion by 2026.

Dubbed its “Lace-Up” plan, the new strategy will aim to grow Foot Locker’s business to more than $9.5 billion in annual revenue by 2026 by diversifying its brand portfolio, relaunching the Foot Locker brand with new store formats focused on an off-mall presence, maximizing its loyalty program and investing in technology to enhance the customer journey.

Dillon also said the business is back on track with Nike, an important brand in the retailer’s overall mix.

“My team and I have spent a great deal of time with Nike revitalizing our partnership, developing a shared vision of the future marketplace,” said Dillon, who called out that she was donning a pair of Nike Air Max 97s during the presentation. She added that Foot Locker and Nike are focusing on key strategic areas such as basketball, kids and sneaker culture, and are sharing data and insights to plan their strategies together.

“The fruits of our renewed commitment to one another will begin to show up in holiday this year as we build increasing momentum to 2024 and the 50th anniversary of Foot Locker,” she said.

Foot Locker chief merchandising officer Chris Santaella added that the partnership is focused on creating a strategy that is “complementary to the Nike direct-to-consumer strategy.”

As the standout brand in the retailer’s portfolio, Nike will make up between 55 percent and 60 percent of Foot Locker’s total sales mix by 2026, Santaella said. Nike made up 70 percent of sales in 2021 and 75 percent of sales in 2020.

The news marks a rapid turn of events in the relationship. Last year, Foot Locker said the amount of Nike product in stores would be significantly less as Nike accelerated its shift toward d-to-c sales. This move initially caused the retailer to post a bleak outlook for 2022, though Foot Locker said it managed to churn out better-than-expected results for the third quarter, the first period in which the diminishment of Nike product was meant to be felt in stores. Nike sales were also higher than expected in the fourth quarter.

Prior to the reversal, analysts were hopeful that under Dillon’s stewardship, the Nike-Foot Locker partnership could be restored to some of its former glory.

“Since Dillon came aboard last August, the tone of the Nike-Foot Locker relationship seems to have become warmer, and it’s possible that they strike a positive tone on the business with Nike,” wrote Wedbush analyst Tom Nikic in a note to investors last week.

In addition to a renewed focus on basketball product, Santaella said Foot Locker and Nike will work in tandem to “develop the next generation of sneaker enthusiasts” by aligning on product for Kids Foot Locker. He also noted that Nike and Foot Locker will continue to partner on celebrating key sneaker moments. This year, both companies will partner to celebrate the 25th anniversary of the Tuned Air franchise. And in 2024, the two will partner on a product concept to celebrate Foot Locker’s 50-year anniversary, which will also celebrate the retailer’s partnership with Nike.

While Nike will remain a key brand partner for Foot Locker, Santaella and Dillon noted the retailer plans to lean into other brands such as Adidas, Puma, New Balance, Crocs, Hoka, On and Under Armour.

“There are more consumers seeking more brands to support their desire to wear sneakers on more occasions,” Santaella said.

In the fourth quarter, total sales decreased by 0.3 percent, beating the company’s expectations from the third quarter, which had sales down between 8 percent and 10 percent. Net income decreased to $19 million. Non-GAAP net income decreased to $92 million. Non-GAAP EPS decreased to $0.97 per share, ahead of analysts’ expectations of $0.51. Comparable-store sales increased 4.2 percent.

For fiscal years 2024 through 2026, Foot Locker expects total sales growth of between 5 percent and 6 percent, comparable sales growth of between 3 percent and 4 percent and adjusted EPS growth in the low- to mid-20s.

The retailer also outlined its guidance for the full fiscal year of 2023, and expects sales to be down between 3.5 percent and 5.5 percent. Comparable sales are expected to be down between 3.5 percent and 5.5 percent. Non-GAAP EPS is expected to be in the range of $3.35 and $3.65.

“We are entering 2023 with a focus on resetting the business — simplifying our operations and investing in our core banners and capabilities to position the company for growth in 2024 and beyond,” Dillon said in a statement.

Here’s a closer look at the four key pillars of the new strategy:

Expanding sneaker culture
Foot Locker wants to tap into different classes of sneaker consumers — from sneaker mavens to deal seekers — to grow its market share. To do this, Foot Locker plans to capitalize on key sneaker moments and anniversaries while offering consumers a broad selection of brands and styles. Exclusive launches and collaborations will also fuel demand.

Part of this pillar involves reigniting a strong brand partnership with Nike, which will remain Foot Locker’s largest brand by sales.

In addition to a renewed focus on basketball product, Foot Locker and Nike will align on product for Kids Foot Locker and partner on celebrating key sneaker moments, such as the 25th anniversary of the Tuned Air franchise this year and Foot Locker’s 50th anniversary in 2024.

Foot Locker also plans to lean into other brands such as Adidas, Puma, New Balance, Crocs, Hoka, On and Under Armour.

Beefing up the portfolio
The second pillar focuses on optimizing Foot Locker’s fleet and unique store banners. This involves closing underperforming stores, opening new formats in off-mall locations and positioning the Foot Locker brand as a community builder. Overall, Foot Locker plans to close about 400 locations to focus on higher performing doors.

At Kids Foot Locker, the goal is to “develop the next generation of sneaker enthusiasts” by leveraging the chain’s high-heat assortment of kids merchandise, Santaella said.

At Champs, Foot Locker will focus on serving an active and wellness-focused consumer. WSS will continue to serve the Latine market and capture more demand in that growing demographic. In Japan, the company’s Atmos banner will serve as a ground for innovation while being rooted in Japanese culture.

The Asia business is also getting an overhaul: Foot Locker said it would close all stores and e-commerce operations in Hong Kong and Macau and convert business to to a license model in Singapore and Malaysia. In Indonesia, leading lifestyle retailer MAP Active will take over Foot Locker operations in Singapore and Malaysia and grow the company’s presence in new markets as well.

Growing relationship with customers
Foot Locker wants to connect to consumers through a variety of channels, including in stores, digitally, on social media and via events. A key part of this relationship will come from a renewed focus on the FLX loyalty program, which Foot Locker said will win over more members via its integration into the sales journey.

In the long-term, Foot Locker is aiming to have loyalty sales account for 70 percent of total sales, up from 25 percent currently. The company also plans to integrate paths to join FLX and Nike’s loyalty programs as well, further cementing the relationship between the two entities.

Omnichannel growth
Along with its in-store experience revamp, Foot Locker also sees an opportunity to grow the percentage of its digital sales. By 2026, Foot Locker aims to have digital sales penetration be about 25 percent of sales, or about $2.5 billion.

At the same time, the company wants to blend both digital and physical channels into one seamless omnichannel experience. To do this, Foot Locker plans to relaunch its app in 2024 and also plans to optimize certain omnichannel capabilities, such as being able to see a store’s inventory availability in real-time and offering a variety of fulfillment options for online orders.

FT : RWE criticises US ban on imports from China’s Xinjiang region

RWE criticises US ban on imports from China’s Xinjiang region
Germany’s biggest utility makes rare attack on Washington’s attempt to pressure Beijing over alleged human rights abuses

Germany’s biggest utility has attacked a US ban on imports from China’s Xinjiang region, warning that it could “significantly hinder plans to build a green energy infrastructure”.

RWE said on Tuesday that the import of solar modules from Asia was now subject to “stringent checks” after Washington last year enacted a ban on all imports from the Chinese province where there have been allegations of human rights violations.

Germany’s largest power producer, which has expanded aggressively into renewable energy, including in the US, said it had been suffering “considerable project delays” as a result of what it called the time-consuming reviews of solar module deliveries.

“State-imposed restrictions on cross-border trade could also significantly hinder plans to build a green energy infrastructure,” the company said in its annual report. “We see an elevated risk of this being the case in the USA.”

It added: “If the USA continues to impede the procurement of solar panels, then it is possible that our photovoltaic expansion initiatives could fall behind schedule.”

The north-western province of Xinjiang has been an important global hub for the production of goods from cotton to silica-based products that are used in solar panel modules.

Business lobby groups had warned that the Uyghur Forced Labor Prevention Act, signed into law by President Joe Biden in 2021, would pose a significant compliance challenge for western businesses operating in China due to the difficulties of conducting audits of supply chains.

RWE’s complaint makes it one of the only western companies to publicly criticise legislation designed to pressure Beijing over Xinjiang. The UN has warned that crimes against humanity may be taking place against interned Muslim Uyghur and other minorities in the province. China denies the claims.

The criticism from RWE also underlines the tension between the Biden administration’s ambitions to boost renewable energy production and its efforts to upbraid China. The EU also faces a similar dilemma.

In Germany, a new supply chain law came into force at the start of this year that requires companies with more than 3,000 workers to implement systems to check whether or not their suppliers are abusing human rights.

RWE’s intervention came as the company reported better than expected earnings before interest, taxes, depreciation and amortisation of €6.3bn for last year. The group pledged to raise its dividend in 2023 and scale up its investments in renewables.

>>> Europe : Brokers Upgrades & Downgrades - 21st of March 2023 V3(++)

>>> Up
* Altri Raised to Buy at JB Capital Markets; PT 6.30 euros
* Axfood Raised to Buy at DNB Markets; PT 280 kronor
* Axfood Raised to Buy at Carnegie (++)
* Emerson Electric Raised to Overweight at Morgan Stanley; PT $96
* Investors House Raised to Reduce at Inderes; PT 5 euros
* J. Martins Raised to Outperform at Exane; PT 23.50 euros (++)
* Kojamo Raised to Buy at OP Corporate Bank; PT 13 euros (Yest. pm)
* Meta Platforms Raised to Overweight at Morgan Stanley; PT $250
* Nel Raised to Add at AlphaValue/Baader
* Nordea Bank Raised to Overweight at Barclays; PT 139.26 kronor
* Rockwool Raised to Buy at DNB Markets; PT 1,875 kroner (++)
* Sainsbury Raised to Outperform at Exane; PT 300 pence (++)
* Stockmann Raised to Accumulate at Inderes; PT 2.10 euros (+)
* TI Fluid Raised to Hold at Jefferies; PT 100 pence
* TotalEnergies Raised to Overweight at Morgan Stanley
* Odfjell Drilling Raised to Hold at SEB Equities; PT 26 kroner (Yest. pm)

>>> Down
* Adobe Cut to Accumulate at Phillip Secs; PT $402
* Alm Equity Cut to Hold at Arctic Securities; PT 535 kronor
* Applus Cut to Hold at Jefferies; PT 8 euros
* Handelsbanken Cut to Equal-Weight at Barclays; PT 105 kronor
* Interroll Cut to Neutral at Exane; PT 3,200 Swiss francs (++)
* InterContinental Hotels Cut to Sell at Redburn (+)
* INTO BB Cut to Accumulate at KBC Securities (+)
* Luceco Cut to Hold at Numis; PT 130 pence (+)
* Melia Hotels Cut to Sell at UBS (++)
* Newron Pharma Cut to Add at Baader Helvea; PT 7.20 Swiss francs
* CORRECT: Novozymes Still Rated Buy at SEB Equities (++)
* Studentbostader i Norden Cut to Hold at Arctic Securities
* Synlab Cut to Hold at HSBC; PT 9 euros
* UniCredit Cut to Neutral at Intermonte; PT 17.80 euros (Yest. pm)

>>> Initiation
* Bechtle Re-Initiated Buy at Bankhaus Metzler; PT 50 euros (+)
* Beijer REF Resumed Buy at Nordea; PT 204 kronor
* Eurogroup Laminations Rated New Buy at Intesa Sanpaolo (+)
* Eurogroup Laminations Rated New Outperform at Exane (++)
* Gentili Mosconi Rated New Buy at Equita; PT 4.85 euros (Yest. pm)
* Multiconsult Rated New Buy at DNB Markets; PT 170 kroner (Yest. pm)
* OHB SE Rated New Neutral at Oddo BHF; PT 35 euros
* O'Reilly Automotive Rated New Hold at Baptista Research; PT $865

>>> Call
* Bernstein Strategists Cautious on Value as More Eyes on Earnings (+)
* IHG Cut to Sell at Redburn on More Cautious Hotels Outlook (+)
* Partners Group’s Dividend Boost Shows Faith in Outlook: Vontobel (+)
* RWE Guidance Beat, Higher Dividend Set Positive Tone: Jefferies (+)
* Rockwool Jumps as DNB Raises, Says Margin Guidance Conservative (++)
* TotalEnergies Raised at Morgan Stanley on Upstream Strength

>>> Europe : Brokers Upgrades & Downgrades - 21st of March 2023 V2(+)

>>> Up
* Altri Raised to Buy at JB Capital Markets; PT 6.30 euros
* Axfood Raised to Buy at DNB Markets; PT 280 kronor
* Emerson Electric Raised to Overweight at Morgan Stanley; PT $96
* Investors House Raised to Reduce at Inderes; PT 5 euros
* Kojamo Raised to Buy at OP Corporate Bank; PT 13 euros (Yest. pm)
* Meta Platforms Raised to Overweight at Morgan Stanley; PT $250
* Nel Raised to Add at AlphaValue/Baader
* Nordea Bank Raised to Overweight at Barclays; PT 139.26 kronor
* Stockmann Raised to Accumulate at Inderes; PT 2.10 euros (+)
* TI Fluid Raised to Hold at Jefferies; PT 100 pence
* TotalEnergies Raised to Overweight at Morgan Stanley
* Odfjell Drilling Raised to Hold at SEB Equities; PT 26 kroner (Yest. pm)

>>> Down
* Adobe Cut to Accumulate at Phillip Secs; PT $402
* Alm Equity Cut to Hold at Arctic Securities; PT 535 kronor
* Applus Cut to Hold at Jefferies; PT 8 euros
* Handelsbanken Cut to Equal-Weight at Barclays; PT 105 kronor
* InterContinental Hotels Cut to Sell at Redburn (+)
* INTO BB Cut to Accumulate at KBC Securities (+)
* Luceco Cut to Hold at Numis; PT 130 pence (+)
* Newron Pharma Cut to Add at Baader Helvea; PT 7.20 Swiss francs
* Novozymes Cut to Hold at SEB Equities; PT 440 kroner (Yest. pm)
* Studentbostader i Norden Cut to Hold at Arctic Securities
* Synlab Cut to Hold at HSBC; PT 9 euros
* UniCredit Cut to Neutral at Intermonte; PT 17.80 euros (Yest. pm)

>>> Initiation
* Bechtle Re-Initiated Buy at Bankhaus Metzler; PT 50 euros (+)
* Beijer REF Resumed Buy at Nordea; PT 204 kronor
* Eurogroup Laminations Rated New Buy at Intesa Sanpaolo (+)
* Gentili Mosconi Rated New Buy at Equita; PT 4.85 euros (Yest. pm)
* Multiconsult Rated New Buy at DNB Markets; PT 170 kroner (Yest. pm)
* OHB SE Rated New Neutral at Oddo BHF; PT 35 euros
* O'Reilly Automotive Rated New Hold at Baptista Research; PT $865

>>> Call
* Bernstein Strategists Cautious on Value as More Eyes on Earnings (+)
* IHG Cut to Sell at Redburn on More Cautious Hotels Outlook (+)
* Partners Group’s Dividend Boost Shows Faith in Outlook: Vontobel (+)
* RWE Guidance Beat, Higher Dividend Set Positive Tone: Jefferies (+)
* TotalEnergies Raised at Morgan Stanley on Upstream Strength